StatFinn (est. 2005) and EPID Research (est. 2010) together as a merged company offer a full range of services in Clinical Trial Biostatistics and Data Management, Epidemiology and Scientific Real-World Evidence that covers the clinical development life cycle – from Phase I to Phase IV and beyond.

Clinical Trials – Data Management and Statistics
We are a prominent force and expert in clinical trial data management and biostatistics. We provide global services focused in clinical trial Statistics, Programming and Data Management for clients ranging from small/virtual biotech to large Pharma.

Real-World Evidence
We provide Real-World Evidence (RWE) by specialising in high quality pharmacoepidemiological research. We provide research services for pharmaceutical companies, health care organisations and authorities. Our studies provide information on safety, effectiveness, adverse effects and costs of drug treatment.

We study the actual use and effects of drugs in large numbers of people by utilising Real-World Data from various health registers with patient-level information on drug prescriptions, diagnoses, treatments and outcomes. Our methodology combines clinical, pharmacological, epidemiological and statistical knowledge.

We act as a single point of contact for our clients. We coordinate all study actions with all possible partners. Studies performed by us do not require a massive study infrastructure because information accumulates in the data sources during normal health care procedures. Our process is fast, transparent, repeatable and traceable. This results in a cost-efficient way of evaluating the risk-benefit profiles of medical treatments.